LiveDrop Bio

What LiveDrop Bio does

LiveDrop Bio (legally LiveDrop SA) is a Belgian life-science instrument company founded in 2022 and headquartered at the GIGA Institute in Liège. It develops benchtop droplet microfluidic devices that encapsulate single cells or cell clusters in picoliter-to-nanoliter droplets for high-throughput screening and 3D cell culture. The portfolio centers on two flagship platforms — ModaFlow™ for single-cell antibody discovery (with 5-color multiplexing, real-time imaging, and the proprietary D-Sire® surface assay) and OneFlow™ for scalable spheroid and organoid manufacturing — complemented by the DispenCell single-cell dispenser, D-Sire® assay reagents, and single-use chip consumables. The technology stack is built around patented SMART Fluidic zero-dead-volume sample handling, multi-laser optical detection (405/488/561/638 nm), and integrated HD imaging at up to 2,000 frames per second.

The company serves pharmaceutical and biotechnology companies developing therapeutic antibodies and cell therapies (including named enterprise users Sanofi and Cellistic), academic and research institutions (Karolinska Institute, SciLifeLab, CER Group, GIGA, INSA, Imperial), and adjacent CRO customers. LiveDrop monetizes through direct, quote-based enterprise sales of capital instruments and recurring consumables (chips, cartridges, assay reagents), supplemented by professional services for assay development, training, and technical support. GTM is enterprise field sales with a physical Live Demo Center at GIGA (opened November 2023) and a US business development presence established in October 2025 via a hire in the Washington DC Metro Area.

Recent strategic activity emphasizes ecosystem buildout and geographic expansion: strategic partnerships with MicroOmix (antibody discovery chemistry, October 2024), Cellistic (iPSC allogeneic cell therapy, FUNDROP program), Xomexbio and ExoBiologics (exosome therapeutics, EXOFASTTRACK), and Emulseo (reagent compatibility), alongside national press coverage in Le Figaro (February 2025) and multi-year Belgian ATMP development programs. The company holds a filed/pending patent on SMART Fluidic Technology and registered trademarks covering D-Sire® and DispenCell.

Name

LiveDrop Bio

Legal name

LiveDrop SA

Website

https://livedrop-bio.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

LiveDrop Bio builds benchtop droplet microfluidic instruments (ModaFlow, OneFlow, DispenCell) for high-throughput antibody discovery and 3D cell culture, selling via direct enterprise sales to pharmaceutical, biotech, and academic research customers across Europe and the US.

Ownership category

akta.pro rank

Product category

Microfluidic Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)

akta.pro secondary industries

In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

Keywords

• Droplet microfluidics
• Antibody discovery platforms
• Single-cell screening
• Microfluidic instruments
• 3D cell culture

Headquarters

HQ city

Liège

HQ country

Belgium

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instrument Sales: Sale of ModaFlow and OneFlow microfluidic instruments - benchtop devices for droplet biology research
2. Consumables: Single-use cartridge chips and accessories for microfluidic experiments
3. Professional Services: Custom assistance for assay development, training programs, and technical support for implementing droplet biology workflows

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

LiveDrop Bio designs, manufactures, and sells benchtop droplet microfluidic instruments (ModaFlow™ and OneFlow™) along with single-use chips, single-cell dispensers (DispenCell), and proprietary D-Sire® assays. The instruments enable high-throughput single-cell encapsulation, screening, and sorting for antibody discovery as well as scalable production of 3D cell models (spheroids, organoids) for biomedical research.

Product overview

LiveDrop Bio offers an integrated platform of droplet microfluidic instruments for high-throughput cell biology and microbiology applications. The core products are ModaFlow™ (the most advanced droplet microfluidic device for single-cell screening, sorting, and antibody discovery) and OneFlow™ (a scalable platform for 3D cell culture spheroid and organoid manufacturing). These benchtop instruments use proprietary droplet technology to encapsulate cells in picoliter to nanoliter droplets for various assays. The product portfolio is complemented by DispenCell for single-cell plating, D-Sire® assay reagents, and single-use cartridge consumables. All instruments feature integrated imaging, intuitive touchscreen interfaces, and zero dead volume designs for maximum sample efficiency.

Differentiator

Problem solved

Functional benefit

Brands

• ModaFlow: The most advanced droplet microfluidic device for high-throughput screening of antibody-producing cells with single-cell precision and multiplexing up to 5-plex.
• OneFlow
• D-Sire
• DispenCell

Products and services

• ModaFlow™ The most advanced droplet microfluidic device for high-throughput screening of antibody-producing cells, featuring patented SMART Fluidic zero-dead-volume technology, up to 5-plex multiplexing, and compatibility with D-Sire® assays, FRET-based assays, and reporter cell functional assays. Designed for pharmaceutical antibody discovery teams.
• OneFlow™ Microfluidic platform for high-throughput 3D cell model manufacturing (spheroids, organoids) in nanoliter droplets. Produces up to 50 million droplets per hour, supports encapsulation from single cells to 200 cells, and is upgradable to ModaFlow™ specifications. Aimed at academic, biotech, and pharma researchers.
• DispenCell Impedance-based single-cell dispenser that operates at less than 0.2 psi (as gentle as manual pipetting) and provides traceable proof of clonality. Pipettes into 96-well plates in 10 minutes with disposable tips to avoid cross-contamination. Used for downstream workflows from LiveDrop instruments.
• D-Sire® Assays Signal relocation assay technology for antibody detection on droplet surfaces, providing highly sensitive and specific detection when used with the ModaFlow™ platform for antibody discovery workflows.
• Chips and Cartridges Single-use microfluidic chips and cartridges available from LiveDrop's catalog or custom-manufactured for specific experimental requirements, used with ModaFlow™ and OneFlow™ instruments.
• Professional Services Custom assistance for assay development, training programs, and technical support to help pharmaceutical, biotech, and academic customers implement droplet biology workflows with LiveDrop instruments.

Quantifiable outcome

• Reduce costs and enhances efficiency in antibody discovery
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• MicroOmixcoreStrategic or Co-development Partner · 8 October 2024Strategic collaboration combining LiveDrop's microfluidic instruments with MicroOmix's patented chemistry to drive faster, more targeted antibody discovery for cancers, neurodegenerative, and autoimmune diseases. This partnership aims to significantly reduce screening times and accelerate development of antibody-based therapies.
• CellisticcoreStrategic or Co-development Partner · 1 January 2024LiveDrop contributes technology to Cellistic's iPSC allogeneic cell therapy platforms (Pulse and Echo). Involvement in FUNDROP study (coordinated by Cellistic) for cell therapy product development over 3 years. Enhances cell line development precision and accelerates manufacturing processes.
• Xomexbio + ExoBiologicscoreStrategic or Co-development Partner · 1 January 2024LiveDrop involved in EXOFASTTRACK study coordinated by Xomexbio and ExoBiologics, accelerating development of therapeutic candidates for rapid clinical evaluation.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cytena (BICO): Cytena (a BICO company) makes single-cell dispensing instruments (e.g., c.sight) that overlap directly with LiveDrop's DispenCell product, serving similar cell line development and antibody discovery use cases.
• Dolomite Bio (Blacktrace Holdings): Dolomite Bio produces droplet microfluidic instruments (Nadia, α-Memteck) for single-cell research including scRNA-seq and antibody discovery. Comparable instrument form factor and customer base in academic and pharma labs.
• Sphere Fluidics: Sphere Fluidics develops droplet-based microfluidics instruments (e.g., Cyto-Mine) for single-cell screening and analysis, particularly in antibody discovery and cell therapy. It is the closest direct competitor to LiveDrop's ModaFlow in functionality and target market.
• Berkeley Lights (Bruker Cellular Analysis): Berkeley Lights (now part of Bruker) offers the Beacon platform for optofluidic single-cell screening and sorting, directly competing with LiveDrop's ModaFlow in antibody discovery and cell line development workflows.

Emerging players

• AbCellera Biologics: AbCellera operates a proprietary antibody discovery platform using single-cell microfluidic screening and is a direct competitor for antibody discovery CRO/drug-discovery contracts — but operates as a discovery services company rather than a tools vendor.

Broad incumbents

• Becton Dickinson (BD Biosciences): BD's flow cytometry and single-cell sorting instruments (FACSAria, BD FACSDiscover) serve overlapping immunology and antibody discovery customers. BD represents a major incumbent that could expand into the high-throughput droplet screening category.
• Bruker Cellular Analysis: Bruker, through its acquisition of Berkeley Lights, offers the Beacon single-cell optofluidics platform directly competing with LiveDrop's ModaFlow. Broader Bruker proteomics and biopharma portfolio creates cross-selling leverage that LiveDrop lacks.
• 10x Genomics: 10x Genomics dominates single-cell analysis with Chromium and other platforms, serving overlapping antibody discovery and cell biology customers. While not droplet-microfluidic in the same mode as LiveDrop, it sets the competitive benchmark for single-cell tools and can expand into adjacent workflows.
• Standard BioTools (formerly Fluidigm): Standard BioTools offers mass cytometry and microfluidic single-cell analysis platforms (Hyperion, CyTOF), overlapping with LiveDrop's high-content single-cell screening applications in immunology and pharma research.
• Sony Biotechnology (Cell Sorter SH800): Sony Biotechnology markets high-speed cell sorters (SH800, CGX10) used in antibody discovery and cell therapy labs. Comparable customer base (pharma, biotech, academia) and adjacent use cases in single-cell screening and sorting workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/livedrop

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LiveDrop Bio